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INTRODUCTION
Despite improvement, UK survival for the 
five most common gynaecological cancers 
(ovarian, cervical, endometrial, vagina, 
and vulval) lags behind that in comparable 
countries such as France and Germany.1 The 
relatively low survival in the UK may reflect 
later diagnosis, with delayed referral from 
primary care contributing.2 Gynaecological 
cancer is more likely than other cancer 
types to be affected by less timely diagnosis.3 
Several primary care-based initiatives have 
been introduced to try to improve survival 
through earlier diagnosis, including patient 
education, urgent suspected cancer referral 
(USCR) guidelines, risk assessment tools, 
and improved access to diagnostic testing, 
but it is unknown if these initiatives have 
improved morbidity and mortality.4 USCR 
guidelines for suspected gynaecological 
cancer recommend the use of pelvic 
examination (abdominal palpation and 
bimanual examination with or without 
visualisation of the cervix), although its 
effect is yet to be determined.5,6 
Research into early diagnosis of cancer 
is complex. The diagnostic pathway of 
cancer consists of several discrete stages, 
from when a patient notices a worrying 
symptom to the pathological confirmation. 
These stages are described in the Aarhus 
statement (Figure 1).7 Fully understanding 
each stage could inform effective 
interventions to reduce overall diagnostic 
delay. However, there is a paucity of 
coherent evidence to inform interventions. 
Therefore, this systematic review aimed to 
address the research question: what factors 
influence patient and primary care delay in 
the diagnostic pathway of gynaecological 
cancer?
METHOD
A systematic narrative review was 
conducted. A computerised database 
search was performed in September 
2014 and updated on 17 March 2017. The 
Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) 
criteria were followed.
Search strategy
The search strategy included three terms, 
their synonyms, and MeSH terms: primary 
care, gynaecological cancer, and diagnosis. 
The full strategy is available from the 
authors on request. The Cochrane Library 
and MEDLINE and Embase databases 
were searched and citation lists of identified 
articles were searched manually by 
one of the authors. All study types from 
January 2000 to March 2017 were included: 
controlled and uncontrolled quantitative 
studies, and qualitative studies. 
Inclusion and exclusion criteria
Included studies:
•	 were based in primary care; 




Gynaecological cancers are the second most 
common female cancer type, with survival 
rates in the UK lower than in many comparable 
countries. A potentially important factor in the 
UK’s poorer cancer outcomes is diagnostic 
delay; gynaecological cancers are the cancer 
type most likely to be affected by less timely 
diagnosis.
Aim
To examine current evidence for factors that 
contribute to patient and primary care delays 
in the diagnostic pathway of gynaecological 
cancer.
Design and setting
A systematic review of the available literature. 
Method
PRISMA guidelines were followed. MEDLINE 
and Embase databases and the Cochrane 
Library were searched using three terms: 
primary care; gynaecological cancer; and 
delay. Citation lists of all identified articles 
were searched. Two authors independently 
screened the titles, abstracts, and full texts of 
publications. Data extraction was performed 
by one author and quality assured by a second 
reviewer in a 20% sample of selected articles. 
Synthesis was narrative.
Results
A total of 1253 references was identified, of 
which 37 met the inclusion criteria. Factors 
associated with delayed diagnosis were 
categorised as either patient factors (patient 
demographics, symptoms or knowledge, 
and presentation to the GP) or primary care 
factors (doctor factors: patient demographics, 
symptoms or knowledge, and referral process); 
and system factors (such as limited access to 
investigations).
Conclusion
Delayed diagnosis in the patient and primary 
care intervals of the diagnostic journey 
of gynaecological cancer is complex and 
multifactorial. This review identifies areas of 
future research that could lead to interventions 
to enable prompter diagnosis of gynaecological 
cancers. 
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gynaecological cancer or symptoms 
potentially indicative of gynaecological 
cancer, and primary care practitioners 
who were GPs; and
•	 described referrals from primary to 
secondary care and/or stages of the 
diagnostic pathways as described in the 
Aarhus statement.7
Excluded studies involved:
•	 non-English articles; 
•	 articles from low- and medium-income 
countries; and
•	 editorials, unpublished work, and 
academic theses. 
Study selection 
Titles, abstracts, and full articles were 
sequentially screened by one author against 
the inclusion and exclusion criteria. The 
same author obtained full-text articles for 
all eligible abstracts. Any disagreements 
were resolved by discussion between two 
researchers.
Quality appraisal
Each included article was assessed using 
the relevant Critical Appraisal Skills 
Programme (CASP) tool. Well-established 
CASP tools are validated for the study 
methodologies included in the review.
Data extraction and analysis
Data were extracted from eligible articles 
to a data collection form. The full data 
collection form is available from the 
authors on request. Data extraction was 
performed by one author. Twenty per 
cent of the articles were independently 
reviewed by one of two authors. Synthesis 
was narrative.8 Overarching themes were 
identified after initial reading. Three main 
themes emerged inductively after detailed 
reading. Re-reading of the included articles 
allowed cross-referencing of data to these 
themes and development of subthemes.
RESULTS
A PRISMA diagram for the systematic 
review is shown in Figure 2. The search 
identified 1253 titles; 210 abstracts were 
screened with 122 being excluded; 88 full 
text articles were assessed with 37 meeting 
the inclusion criteria. Full details of the 
studies are available from the authors on 
request.9–45 The reasons for abstract and 
full article exclusions are given in Figure 2.
Various methodologies were employed: 
15 cohort studies, five retrospective note 
reviews, four questionnaire studies, three 
qualitative studies, two mixed methods 
studies using both qualitative and data 
analysis, three telephone surveys, one 
cross-sectional analysis, three secondary 
data analysis studies, and one review. 
Poor study quality did not affect inclusion 
of articles. A detailed cohort quality checklist 
is available from the authors on request. 
Initial reading of the data identified three 
themes that mapped on to the diagnostic 
intervals described in the Aarhus statement 
(patient factors, doctor factors, and system 
factors).7 Further analysis identified 
subthemes as outlined below.
Patient factors
Patient demographics. Four articles 
demonstrated the lack of influence 
of socioeconomic status (SES) on the 
diagnostic journey,9–12 although one 
demonstrated diagnostic delay in patients 
of lower SES diagnosed with endometrial 
cancer.10 In countries where health care 
is based on insurance and payment, low 
income was linked to diagnostic delay and 
delays in treatment.13,14 In Denmark, women 
of higher SES appeared more capable 
How this fits in
Despite its prevalence and evidence that 
it is associated with diagnostic delay, it is 
not clear which factors are important in 
the diagnostic pathway of gynaecological 
cancer. This study shows that diagnostic 
delay is multifactorial, with a complex 
interplay of mutually interdependent 
relationships between patient and primary 
care factors. Identifying areas of further 
research, the study also identifies areas 
where the introduction of a complex 
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Figure 1. The stages of cancer diagnosis according 
to the Aarhus statement.7
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of ‘seeking and sustaining treatment’,15 
reinforcing work that showed women of 
higher SES were more likely to speed up 
health-seeking behaviour.11 Further work 
in Denmark demonstrated a link between 
SES and survival: endometrial and ovarian 
cancer mortality was highest in women 
with low educational attainment, whereas 
survival from cervical cancer was highest 
in those of higher SES.16 Macleod et al 12 
demonstrated no effect of educational 
status on delay; however, Hansen et al 17 
demonstrated decreased delay in those 
with higher educational attainment. Ashing-
Giwa et al 13 found an association between 
lower survival and lower attainment. 
Women of higher educational status are 
more likely to be referred in primary care to 
specialists.18 A pooled analysis of 18 studies 
identified an association between lower 
educational attainment and an increased 
risk of advanced stage at diagnosis of 
ovarian cancer.14 
The effect of ethnicity was mixed. Although 
one author demonstrated black or ethnic 
minority women in the UK were more likely 
to require three or more visits to their GPs 
before referral,19 two demonstrated no link 
with ethnicity and delay.9,12 Poorer survival 
rates were observed in black and Latino 
women in the US,13 and Pacific and Maori 
women in New Zealand,20 suggesting that 
other factors, such as cultural attitudes, 
might influence survival. 
Six studies conducted in the UK, Sweden, 
and Denmark identified age as a factor. Three 
found that females aged ≥75 years and those 
who were housebound were more likely to 
present earlier, along with those patients 
who were retired.21–23 Females of working 
age were more likely to delay presentation,16 
although a review found that age was not 
a factor.12 Patients diagnosed with ovarian 
cancer aged ≤55 years were found to be 
more likely to have had more than three 
consultations before referral.19 Of those 
patients who were referred urgently, older 
patients were more likely to be diagnosed 
earlier than younger patients.23 However, 
when looking at endometrial cancer in 
isolation, older patients were more likely to 
be diagnosed with late-stage disease.15 
Three studies demonstrated that rurality 
and distance from health care increased 
delay.14,20,24 
Symptoms and symptom knowledge. 
Patients were shown to lack knowledge 
of the symptoms of ovarian, cervical, and 
endometrial cancer.25–27 
Abnormal vaginal bleeding is considered 
differently at different stages in life. Two 
authors demonstrated that vaginal bleeding 
symptoms led to less delay than vague 
or gastrointestinal symptoms.12,28 Patient 
delay was greater in cervical cancer than in 
endometrial cancer because bleeding was 
less likely to be considered as a symptom of 
illness in premenopausal women.29 
Seibaek et al 15 suggested that, although 
patients experience ‘bodily sensations’ 
such as abdominal distension or pain, it is 
organisational, cultural, and social factors 
that determine whether these ‘sensations’ 
are then interpreted as symptoms that 
lead to health-seeking behaviour. Many 
women will put these ‘sensations’ down to 
menopause or a non-gynaecological cause. 
Presentation to primary care. Less delay 
was seen in women who undergo regular 
screening.12,20 Consulting with more than 
one GP before diagnosis has been linked to 
later disease stage.14 
The International Cancer Benchmarking 
Partnership examined the effect of cancer 
awareness and beliefs on cancer survival in 
different countries. It found that the UK had 
the ‘highest mean barriers to symptomatic 
presentation’, for example, embarrassment 
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and worry about what the doctor might find, 
when compared with other high-income 
countries.30
Doctor factors
Patient demographics. GPs in Denmark 
were less likely to delay referring women 
with higher SES.17 In a systematic review, 
Macleod et al 12 found that lower educational 
status was associated with referral delay. 
Three articles found that increasing 
patient age increased delay,15,29,31 although 
Robinson et al 16 found delay was greater if 
the patient was younger; this was related to 
menstrual status. Marital status was found 
not to affect referral delay.7 Rurality was 
associated with delay in one article.16
Symptoms. Non-specific, atypical, and 
gastrointestinal symptoms are more likely 
to be associated with delay.12,14,19,25,28,32 
Doctor failure to appreciate the significance 
of symptoms, especially postcoital bleeding, 
led to longer delays in women diagnosed 
with cervical cancer, whereas older women 
with postmenopausal bleeding had shorter 
delay.33 Jensen et al 34 explored the effect 
of ‘suboptimal clinical decisions’ and found 
that endometrial cancer was least likely to 
have involved suboptimal clinical decisions, 
whereas cases involving ovarian cancer 
and non-alarm symptoms were most 
likely to involve this deviation in quality. 
Non-investigation of symptoms, including 
postmenopausal bleeding, is associated 
with increased delay in diagnosis.26,35 Failing 
to consider cancer as a possible diagnosis 
leads to diagnostic delay.33,36 
Misdiagnosis, either through treating 
patients symptomatically or by relating 
symptoms to other conditions, can also lead 
to referral and diagnostic delay,12,32,35 as can 
comorbidities.14,36 
Referral process. Not being referred to 
gynaecology,35,37 non-urgent referral,26,35 
and referring without notifying a suspicion of 
cancer on the referral12 were all associated 
with diagnostic delay. 
In patients with multiple consultations 
before referral, a lack of follow-up led to 
delay.27,35 Poor communication can lead to 
patients not re-presenting with persistent 
symptoms or follow-up.35,38
Poor communication can affect a GP’s 
ability to make a differential diagnosis, 
which can cause delay.34,35 For patients 
referred for investigations by their GP, false-
negative results led to delayed diagnosis.34 
The effect of pelvic examination was 
investigated. One article demonstrated no 
association between pelvic examination and 
diagnostic delay, whereas three authors 
demonstrated diagnostic delay when no 
pelvic examination was performed.12,29,33 
The effects of misinterpreting abnormal 
findings as normal was also highlighted.27 
A study of the use of USCR guidelines 
demonstrated no survival difference in 
women with ovarian cancer.39 Jiwa et al 36 
found that those who were referred urgently 
were diagnosed most quickly, although failure 
to satisfy all the criteria for urgent referral 
can lead to delay. In patients diagnosed with 
cervical cancer, there was evidence that 
guidelines were not being used.33 
Further study of USCR guidelines 
has demonstrated that, when used, the 
median diagnostic interval for cervical 
and endometrial cancers was increased, 
although in referrals using National 
Institute for Health and Care Excellence 
symptoms for referral, diagnostic intervals 
decreased.40 However, this study excluded 
patients aged ≤40 years. Vandborg et al 29 
found some association between lack 
of alarm symptoms and long delays of 
>90 days, with 39% of those diagnosed with 
gynaecological cancer consulting with non-
alarm symptoms, although the study only 
involved small numbers. Ovarian cancer 
diagnosis was quicker if referrals were 
USCR referrals (regardless of specialty 
referred to) compared with those referred 
routinely.41 
The primary–secondary care interface was 
highlighted by two authors who commented 
on the need for senior clinicians to screen 
referrals and the resulting delay from slow 
communication of test results.38,42 Waits 
between secondary care appointments lead 
to delay.19 
System factors
Shorter system delays were seen in wealthy 
females and patients referred by GPs who did 
not see them routinely. Patients described as 
‘less compliant’ and those who had a high 
alcohol intake had greater system delays, as 
did patients referred by a female GP.17 
It has been suggested that the gatekeeper 
role performed by GPs delays diagnosis.30,37 
Poor access to investigations, both actual 
and perceived, can lead to delay.12,21,36,37 
DISCUSSION
Summary
Diagnostic delay in gynaecological 
cancer is multifaceted and complicated. 
However, this inductive narrative review 
has identified symptom type, symptom 
knowledge, symptom investigation, and 
primary–secondary care interface as the 
factors most associated with differences 
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in diagnostic delay for patient, doctor, and 
system intervals as described by Aarhus.7 
Analysis by themes can be limiting and 
there are some difficulties categorising 
patient, doctor, and system factors because 
of their interdependency: some subthemes 
are embedded in all three major themes. 
Patient age appears to be an important 
factor influencing patient and practitioner 
behaviour. The symptom type is important 
and an absence of alarm symptoms can 
lead to delay. Patients and GPs can lack 
symptom knowledge, which affects patients’ 
decisions to present and clinicians’ decision 
to investigate or refer. Non-investigation of 
symptoms or misdiagnosis can lead to non-
urgent referral or referral to specialties 
other than gynaecology. Communication 
between GPs and patients and GPs and 
secondary care also has impact. 
There was little evidence describing the 
effect of UK and Danish USCR guidelines. Of 
the 21 UK studies included in the review, 15 
were conducted after the introduction of the 
guidelines. Misattribution of symptoms by 
GPs and suboptimal referral were identified 
before and after guideline introduction.27,33,41 
All eight Danish studies were conducted 
after guidelines were introduced.
Strengths and limitations
This review is the first to examine the 
factors influencing patient and primary 
care intervals in the diagnostic pathway 
of gynaecological cancers. It has been 
conducted rigorously and provides a 
summary of the available evidence to 
inform complex interventions to reduce 
diagnostic delay. 
There are some limitations. Despite a 
comprehensive systematic search strategy, 
a paucity of evidence was identified. Almost 
all studies were observational and of variable 
quality. The studies were heterogeneous, 
varying in terms of cancer type, research 
methods, and outcomes, with a focus on 
descriptive work rather than interventions. 
Variance in the definition of delay and in 
the healthcare systems investigated led to 
heterogeneity of patients and practitioners. 
The lack of common methodology does not 
permit definitive conclusions.
Comparison with existing literature
The general diagnostic delay themes 
identified, such as patient socioeconomic 
and educational status, symptom 
knowledge, and misdiagnosis, confirm 
those described previously by other 
authors,12,30,46,47 but this review is the first to 
examine factors specific to gynaecological 
cancer.
Implications for research and practice 
This review has identified specific factors 
that influence patient and primary care 
diagnostic delay.
GPs can be misled by presenting 
symptoms; they should be alert to 
gastrointestinal symptoms and abnormal 
bleeding in premenopausal women, 
which can lead to misdiagnosis, lack of 
examination, and suboptimal referral. 
Another important factor in reducing delay 
is for GPs to have suspicion that the patient 
may have cancer. However, because GPs 
do not see cases of gynaecological cancer 
often, it is important to work out how 
they can differentiate between suspicious 
and non-suspicious vaginal bleeding or 
recognise the significance of gastrointestinal 
symptoms while minimising delay. 
There is a need to understand why 
patients delay presenting and identify 
effective education. Pelvic examination 
appears to be an important factor in 
reducing delayed diagnosis; therefore, 
research might be useful to find out how to 
make it an acceptable procedure to patients 
in terms of physical and emotional comfort 
and to GPs in terms of time, chaperone 
availability, and skills. Communication is 
key; patients must be reassured that they 
are not wasting GPs’ time and to come back 
if symptoms persist or worsen. 
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